Paul Scherrer Institute, Villigen, Switzerland

Academic/Hospital

Also known as: Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland | Paul Scherrer Institut, Center for Proton Therapy | Paul Scherrer Institut, Villigen, Switzerland

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 1, 2015

Last known activity

Jun 30, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 3 trials)

Phase 2 (2 own, 0 via acquisition)

fludeoxyglucose f-18
azafol

Phase 1 (2 own, 0 via acquisition)

177lu-pp-f11n
sacubitril

Indications

Studied for

Thyroid Diseases
Thyroid Neoplasms

Recent trials (3)

NCT06335888CollaboratorPhase 2Jun 30, 2024
NCT03647657CollaboratorEarly Phase 1Oct 31, 2018
NCT02088645CollaboratorPhase 1Apr 1, 2015

Details

Last known activity: Jun 30, 2024